Detalhe da pesquisa
1.
Murine allogeneic CAR T cells integrated before or early after posttransplant cyclophosphamide exert antitumor effects.
Blood
; 141(6): 659-672, 2023 02 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-36201744
2.
Signatures of GVHD and relapse after posttransplant cyclophosphamide revealed by immune profiling and machine learning.
Blood
; 139(4): 608-623, 2022 01 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-34657151
3.
Effect of donor age in patients with acute myeloid leukemia undergoing haploidentical hematopoietic cell transplantation vary by conditioning intensity and recipient age.
Am J Hematol
; 99(1): 38-47, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37850688
4.
Immunosuppressant adherence in adult outpatient hematopoietic cell transplant recipients.
J Oncol Pharm Pract
; 30(2): 322-331, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-37134196
5.
HLA-haploidentical vs matched unrelated donor transplants with posttransplant cyclophosphamide-based prophylaxis.
Blood
; 138(3): 273-282, 2021 07 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-34292325
6.
Posttransplant cyclophosphamide is associated with increased cytomegalovirus infection: a CIBMTR analysis.
Blood
; 137(23): 3291-3305, 2021 06 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-33657221
7.
Incidence and impact of community respiratory viral infections in post-transplant cyclophosphamide-based graft-versus-host disease prophylaxis and haploidentical stem cell transplantation.
Br J Haematol
; 194(1): 145-157, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-34124796
8.
Immune Reconstitution Inflammatory Syndrome as a Posttransplantation Complication in Primary Immunodeficiency With Disseminated Mycobacterium avium.
Clin Infect Dis
; 70(4): 676-679, 2020 02 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-31190050
9.
Optimized Timing of Post-Transplantation Cyclophosphamide in MHC-Haploidentical Murine Hematopoietic Cell Transplantation.
Biol Blood Marrow Transplant
; 26(2): 230-241, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31586477
10.
Prospective Study of a Novel, Radiation-Free, Reduced-Intensity Bone Marrow Transplantation Platform for Primary Immunodeficiency Diseases.
Biol Blood Marrow Transplant
; 26(1): 94-106, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31493539
11.
T Cell Repertoire Evolution after Allogeneic Bone Marrow Transplantation: An Organizational Perspective.
Biol Blood Marrow Transplant
; 25(5): 868-882, 2019 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-30677510
12.
Outcomes of Related and Unrelated Donor Searches Among Patients with Primary Immunodeficiency Diseases Referred for Allogeneic Hematopoietic Cell Transplantation.
Biol Blood Marrow Transplant
; 25(8): 1666-1673, 2019 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-30986499
13.
Development of Grade II Acute Graft-versus-Host Disease Is Associated with Improved Survival after Myeloablative HLA-Matched Bone Marrow Transplantation using Single-Agent Post-Transplant Cyclophosphamide.
Biol Blood Marrow Transplant
; 25(6): 1128-1135, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-30599208
14.
Cytomegalovirus Infection Incidence and Risk Factors Across Diverse Hematopoietic Cell Transplantation Platforms Using a Standardized Monitoring and Treatment Approach: A Comprehensive Evaluation from a Single Institution.
Biol Blood Marrow Transplant
; 25(3): 577-586, 2019 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30342913
15.
Low immunosuppressive burden after HLA-matched related or unrelated BMT using posttransplantation cyclophosphamide.
Blood
; 129(10): 1389-1393, 2017 03 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-28049637
16.
Have haploidentical transplants replaced umbilical cord transplants for acute leukemias?
Curr Opin Hematol
; 25(2): 103-111, 2018 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-29283908
17.
Grade II Acute Graft-versus-Host Disease and Higher Nucleated Cell Graft Dose Improve Progression-Free Survival after HLA-Haploidentical Transplant with Post-Transplant Cyclophosphamide.
Biol Blood Marrow Transplant
; 24(2): 343-352, 2018 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-29055682
18.
Pretransplant Consolidation Is Not Beneficial for Adults with ALL Undergoing Myeloablative Allogeneic Transplantation.
Biol Blood Marrow Transplant
; 24(5): 945-955, 2018 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29275139
19.
Risk-stratified outcomes of nonmyeloablative HLA-haploidentical BMT with high-dose posttransplantation cyclophosphamide.
Blood
; 125(19): 3024-31, 2015 May 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-25814532
20.
Plasma-derived proteomic biomarkers in human leukocyte antigen-haploidentical or human leukocyte antigen-matched bone marrow transplantation using post-transplantation cyclophosphamide.
Haematologica
; 102(5): 932-940, 2017 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-28126963